Literature DB >> 15459022

Will cancer stem cells provide new therapeutic targets?

Fariba Behbod1, Jeffrey M Rosen.   

Abstract

This review presents a brief synopsis of recent progress in the area of cancer stem cells, with emphasis on leukemia and breast cancer, and discusses potential limitations to accomplishing the ultimate goal of eradicating residual disease in cancer.

Entities:  

Mesh：

Year:  2004        PMID： 15459022     DOI： 10.1093/carcin/bgh293

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN： 0143-3334            Impact factor:   4.944


  47 in total

Review 1.  Histological types of breast cancer: how special are they?

Authors:  Britta Weigelt; Felipe C Geyer; Jorge S Reis-Filho
Journal:  Mol Oncol       Date:  2010-04-18       Impact factor: 6.603

2.  On murine mammary epithelial stem cells: discovery, function, and current status.

Authors:  Jeffrey M Rosen
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-04-01       Impact factor: 10.005

Review 3.  Overcoming challenges of ovarian cancer stem cells: novel therapeutic approaches.

Authors:  Cristóbal Aguilar-Gallardo; Emily Cecilia Rutledge; Ana M Martínez-Arroyo; Juan José Hidalgo; Santiago Domingo; Carlos Simón
Journal:  Stem Cell Rev Rep       Date:  2012-09       Impact factor: 5.739

4.  WNT/beta-catenin mediates radiation resistance of mouse mammary progenitor cells.

Authors:  Wendy A Woodward; Mercy S Chen; Fariba Behbod; Maria P Alfaro; Thomas A Buchholz; Jeffrey M Rosen
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-03       Impact factor: 11.205

5.  Aberrant expression of β-catenin and its association with ΔNp63, Notch-1, and clinicopathological factors in oral squamous cell carcinoma.

Authors:  Gokulan Ravindran; Halagowder Devaraj
Journal:  Clin Oral Investig       Date:  2011-09-01       Impact factor: 3.573

Review 6.  Isolation and characterization of human mammary stem cells.

Authors:  R B Clarke
Journal:  Cell Prolif       Date:  2005-12       Impact factor: 6.831

7.  Modification of topoisomerases in mammospheres derived from breast cancer cell line: clinical implications for combined treatments with tyrosine kinase inhibitors.

Authors:  Refael Peleg; Marianna Romzova; Inga Kogan-Zviagin; Ron N Apte; Esther Priel
Journal:  BMC Cancer       Date:  2014-12-03       Impact factor: 4.430

Review 8.  BRCA1--conductor of the breast stem cell orchestra: the role of BRCA1 in mammary gland development and identification of cell of origin of BRCA1 mutant breast cancer.

Authors:  Niamh E Buckley; Paul B Mullan
Journal:  Stem Cell Rev Rep       Date:  2012-09       Impact factor: 5.739

Review 9.  Sheep, wolf, or werewolf: cancer stem cells and the epithelial-to-mesenchymal transition.

Authors:  Jeffrey T Chang; Sendurai A Mani
Journal:  Cancer Lett       Date:  2013-03-14       Impact factor: 8.679

10.  The ontogeny and fate of NK cells marked by permanent DNA rearrangements.

Authors:  Kristy Pilbeam; Per Basse; Laurent Brossay; Nikola Vujanovic; Rachel Gerstein; Abbe N Vallejo; Lisa Borghesi
Journal:  J Immunol       Date:  2008-02-01       Impact factor: 5.422
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.